- Home
- TSBX vs OP Comparison
TSBX vs OP Comparison
Compare TSBX & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- OP
- Stock Information
- Founded
- TSBX 2015
- OP 2021
- Country
- TSBX United States
- OP Greece
- Employees
- TSBX N/A
- OP N/A
- Industry
- TSBX
- OP
- Sector
- TSBX
- OP
- Exchange
- TSBX Nasdaq
- OP Nasdaq
- Market Cap
- TSBX 7.7M
- OP 9.5M
- IPO Year
- TSBX 2023
- OP N/A
- Fundamental
- Price
- TSBX $0.37
- OP $1.36
- Analyst Decision
- TSBX Buy
- OP
- Analyst Count
- TSBX 3
- OP 0
- Target Price
- TSBX $4.75
- OP N/A
- AVG Volume (30 Days)
- TSBX 459.9K
- OP 10.2M
- Earning Date
- TSBX 08-13-2025
- OP 08-06-2025
- Dividend Yield
- TSBX N/A
- OP N/A
- EPS Growth
- TSBX N/A
- OP N/A
- EPS
- TSBX N/A
- OP N/A
- Revenue
- TSBX N/A
- OP $25,702,000.00
- Revenue This Year
- TSBX N/A
- OP N/A
- Revenue Next Year
- TSBX N/A
- OP N/A
- P/E Ratio
- TSBX N/A
- OP N/A
- Revenue Growth
- TSBX N/A
- OP 35.58
- 52 Week Low
- TSBX $0.29
- OP $0.63
- 52 Week High
- TSBX $2.69
- OP $3.17
- Technical
- Relative Strength Index (RSI)
- TSBX 54.35
- OP 48.71
- Support Level
- TSBX $0.33
- OP $1.16
- Resistance Level
- TSBX $0.37
- OP $1.67
- Average True Range (ATR)
- TSBX 0.02
- OP 0.25
- MACD
- TSBX 0.00
- OP -0.10
- Stochastic Oscillator
- TSBX 64.17
- OP 12.90
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.